Related Experiment Videos
Bisfuranoid mycotoxins: their genotoxicity and carcinogenicity
1Department of Environmental Toxicology, University of California, Davis 95616.
Abstract:
Based on the mode of action of AFB1 and the activities of its biologically active intermediates, one may conclude that: 1. The mode of toxic action of the bisfuranoid mycotoxin is through epoxidation of the vinyl ether double bond of their dihydrobisfuran functionality. 2. The DNA and plasma albumin adducts formed in vivo may be useful in the molecular dosimetry of these environmental carcinogens. 3. There appears to be a linear correlation between the steady state levels of AFB1-FAPy-DNA adducts and the carcinogenicity of AFB1. Elucidation of the molecular basis of this correlation may shed light on the mechanism of AFB1-induced carcinogenesis. 4. Consistent appearance of AFB1-DNA adducts in the livers of liver cancer patients tested is supportive of the IARC conclusion that AFB1 is a human carcinogen involved in human primary liver cancer.
Insights
Aflatoxin B1 (AFB1) causes toxicity by epoxidation, forming DNA and albumin adducts. These adducts correlate with carcinogenicity and confirm AFB1 as a human liver cancer agent.
Area of Science:
- Toxicology
- Molecular Biology
- Carcinogenesis
Background:
- Aflatoxin B1 (AFB1) is a bisfuranoid mycotoxin with known toxic effects.
- Understanding the molecular mechanisms of AFB1 toxicity and carcinogenicity is crucial for public health.
Purpose of the Study:
- To elucidate the mode of toxic action of AFB1.
- To investigate the utility of AFB1-DNA and AFB1-albumin adducts in molecular dosimetry.
- To explore the correlation between AFB1-DNA adducts and carcinogenicity.
- To provide evidence supporting AFB1's role in human liver cancer.
Main Methods:
- Analysis of AFB1's mode of action and its biologically active intermediates.
- In vivo studies to detect and quantify DNA and plasma albumin adducts.
- Correlation analysis between adduct levels and carcinogenicity data.
- Detection of AFB1-DNA adducts in liver cancer patients.
Main Results:
- AFB1 toxicity stems from epoxidation of its dihydrobisfuran functionality.
- In vivo DNA and albumin adducts serve as biomarkers for exposure to AFB1.
- A linear correlation exists between AFB1-FAPy-DNA adduct levels and AFB1 carcinogenicity.
- AFB1-DNA adducts were consistently found in the livers of patients with primary liver cancer.
Conclusions:
- The epoxidation of AFB1 is the primary mechanism of its toxic action.
- Molecular dosimetry using AFB1 adducts is a viable approach for assessing exposure.
- The correlation between AFB1-DNA adducts and carcinogenicity provides insights into cancer mechanisms.
- AFB1 is confirmed as a significant etiological factor in human primary liver cancer, supporting IARC classifications.